美股市場個股詳情
RVMD Revolution Medicines
- 56.750
- -0.030-0.05%
收盤價 11/22 16:00 (美東)
- 56.750
- 0.0000.00%
盤後 20:01 (美東)
95.46億總市值-15505市盈率TTM
57.410最高價56.390最低價116.58萬股成交量57.060今開56.780昨收6636.50萬成交額0.76%換手率虧損市盈率(靜)1.68億總股本62.40052周最高6.09市淨率87.19億流通值20.98052周最低--股息TTM1.54億流通股62.400歷史最高--股息率TTM1.80%振幅14.080歷史最低56.925平均價1股每手
關於Revolution Medicines公司
Revolution Medicines Inc是一家臨牀階段的精密腫瘤學公司，致力於開發新穎的靶向療法，以抑制臭名昭著的生長和生存途徑內的難以捉摸的前沿靶標，尤其側重於RAS和mTOR信號通路。 該公司的產品包括RMC-4630，SHP2抑制劑，RAS（ON） 產品組合以及SOS1和4EBP1 / mTORC1程序。
公司介紹
公司代碼RVMD
公司名稱Revolution Medicines
上市日期2020/02/13
發行價格17.00
成立日期2004
CEODr. Mark A. Goldsmith, M.D., PhD
所屬市場納斯達克
員工數量378
年結日12-31
公司地址700 Saginaw Drive
城市Redwood City
省份加利福尼亞州
國家美國
郵編94063
電話1-650-481-6801
董事高管
- 姓名
- 職務
- 年薪
- Dr. Mark A. Goldsmith, M.D., PhD
- President, Chief Executive Officer and Chairman of the Board
- 1041.12萬
- Jack Anders
- Chief Financial Officer and Principal Accounting Officer
- 304.75萬
- Dr. Wei Lin
- Chief Medical Officer
- --
- Margaret A. Horn, J.D.
- Chief Operating Officer
- 439.34萬
- Dr. Mary Pinder-Schenck, M.D.
- Senior Vice President, Head of Medical Affairs
- --
- Xiaolin Wang
- Executive Vice President, Development
- 323.09萬
- Jeff Cislini
- Senior Vice President, General Counsel and Secretary
- --
- Dr. Jing Yi, PhD
- Senior Vice President, Head of Program Leadership.
- --
- Ryan Asay
- Senior Vice President, Corporate Affairs
- --
- Dr. Mason Shih, M.D.
- Senior Vice President, Head of Drug Safety
- --
- Dr. Stephen M. Kelsey, F.R.C.P.,M.D.
- President, Research and Development
- 439.45萬
- Dr. Sushil Patel, PhD
- Independent Director
- 47.52萬
- Dr. Lorence H. Kim, M.D.
- Independent Director
- 49.00萬
- Frank K. Clyburn, Jr
- Independent Director
- --
- Elizabeth McKee Anderson, M.B.A.
- Independent Director
- 48.38萬
- Dr. Thilo Schroeder, PhD
- Independent Director
- --
- Dr. Flavia Borellini, PhD
- Independent Director
- 48.91萬
- Dr. Sandra J. Horning, M.D.
- Independent Director
- 72.00萬
- Dr. Barbara L. Weber, M.D.
- Independent Director
- 48.02萬
- Alexis A. Borisy, A.M.
- Lead Independent Director
- 51.06萬
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據